Bisphenol a increases risk for presumed non-alcoholic fatty liver disease in Hispanic adolescents in NHANES 2003–2010

Table 3 Risk of Suspected Non-Alcoholic Fatty Liver Disease (NAFLD) in Overweight/Obese Adolescents

Risk of Suspected NAFLD^a in overweight/obese participants (BMI^b Z-Score ≥ 1.064)
	All races (n = 327)				Non-hispanic white (n=)		Hispanic (n = 126)
	Unadjusted model^d		Adjusted model^e		Adjusted model^f		Adjusted model^f
	OR (95% C.I.)^c	p-value	OR (95% C.I.)	p-value	OR (95% C.I.)	p-value	OR (95% C.I.)	p-value
Urinary BPA^g Category
0.28–1.3 ng/mL	Reference		Reference				Reference
1.4–2.7 ng/mL	2.86 (0.98–8.29)	0.053	5.56 (1.28–24.06)	0.023	1.29 (0.12–13.89)	0.829	5.00 (1.40–17.93)	0.015
2.8–5.4 ng/mL	2.20 (0.61–7.93)	0.224	3.39 (0.60–19.13)	0.162	1.42 (0.04–45.42)	0.841	1.98 (0.23–17.43)	0.527
≥5.5 ng/mL	2.31 (0.66–8.01)	0.181	6.85 (1.02–46.22)	0.048	0.87 (0.05–16.55)	0.926	5.20 (0.93–29.01)	0.060
Log Transformed BPA
	1.11 (0.71–1.73)	0.644	1.41 (0.74–2.70)	0.285	1.28 (0.19–8.59)	0.787	1.04 (0.58–1.85)	0.896

^aNon-Alcoholic Fatty Liver Disease, ^bBody Mass Index, ^cOdds Ratio (95% Confidence Interval), ^dAdjusted for urinary creatinine, ^eAdjusted for urinary creatinine, gender, age, race, family income to poverty ratio, country of birth, total caloric intake in 24 h, cotinine levels, and survey cycle, ^fAdjusted for urinary creatinine, gender, age, total caloric intake in 24 h, cotinine levels, and survey cycle, ^gBisphenol A

ISSN: 1476-069X